(Q37039386)

17 August 2017

1 reference

title

Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy (English)

1 reference

oral squamous cell carcinoma

17 August 2017

0 references

1 reference

S Choi

1

1 reference

PubMed ID

18096889

17 August 2017

J N Myers

series ordinal

2

1 reference

PubMed ID

18096889

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Journal of Dental Research

17 August 2017

1 reference

17 August 2017

87

1 reference

17 August 2017

1

1 reference

17 August 2017

14-32

1 reference

Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status

17 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Targeted therapies in the treatment of colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Molecular mechanisms of lymphangiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oncogene amplification in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Nuclear factor-kappa B and cancer: its role in prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Matrix metalloproteinases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A genetic progression model of oral cancer: current evidence and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The role of STATs in transcriptional control and their impact on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oncogenes and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Ras mutations in United Kingdom examples of oral malignancies are infrequent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

VEGF-receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

NF-kB in development and progression of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cell cycle regulatory proteins--an overview with relevance to oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cell adhesion: the molecular basis of tissue architecture and morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oncogene activation by chromosome translocation in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Expression of alpha(v)beta6 integrin in oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Telomeres shorten during ageing of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Connecting proliferation and apoptosis in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Changes in the expression of alpha v integrins in oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Epidermal growth factor receptor biology in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oxaliplatin in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Evolution of tumours and the impact of molecular oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The proto-oncogene Bcl-2 and its role in regulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Molecular targeted therapy of head and neck cancer: review and clinical development challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

STAT3 as a therapeutic target in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oral cancer prevention and the evolution of molecular-targeted drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Control of the cell cycle and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Discovery of a novel Raf kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

c-Met: structure, functions and potential for therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Apoptosis: inhibitor or instigator of carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Regulatory effects of gamma-interferon on IL-6 and IL-8 secretion by cultured human keratinocytes and dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A novel cyclin encoded by a bcl1-linked candidate oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The involvement of oncogenes and tumor suppressor genes in the control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Transcriptional regulation of cadherins during development and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

bcl-2 protein in non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

How many mutations are required for tumorigenesis? Implications from human cancer data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Biological significance of c-erbB family oncogenes in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The ErbB/HER receptor protein-tyrosine kinases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Loss of allelic heterozygosity at the harveyras locus in human oral carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Programmed cell death: concept, mechanism and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Telomerase therapeutics for cancer: challenges and new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Nuclear factor-kappaB: a friend or a foe in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Researchers optimistic about sea change in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Telomerase and human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Multiple head and neck tumors frequently originate from a single preneoplastic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cadherin cell adhesion receptors as a morphogenetic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cell adhesion molecules and oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Alphavbeta6 integrin in wound healing and cancer of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Cellular sources of transforming growth factor-alpha in human oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The molecular biology of oral carcinogenesis: toward a tumor progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

STAT proteins: novel molecular targets for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

VEGFs, receptors and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Programmed cell death: apoptosis and oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

Effect of c-Met Expression on Survival in Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

bcl-2 expression in head and neck cancer: an enigmatic prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154405910808700104

10.1177/154405910808700104

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18096889